[Human PAPILLOMA Virus (HPV) vaccine].
A solid tumor related to viral infection is a rare and challenging condition to the medical community raising the possibility to fight and prevent this cancer by vaccine. Cervical cancer, caused by human papillomavirus (HPV), is a major health problem worldwide. The two HPV vaccines approved lately could lead to more than a 70% reduction in cases of cervical cancer and a similar reduction in deaths from the cancer. Pap smear screening significantly (80%) reduced disease incidence and is still useful and needed. In addition to early detection, vaccination will prevent the development of precancerous and cancerous lesion and reduce morbidity, mortality and psychological and social stress as well as stressful and expensive follow-ups in women with suspicious lesions. The vaccinations described will bring to a significant reduction in genital warts incidence, a serious social and psychological burden to the infected population. Practical social and psychological issues are still to be addressed, some of them are: time and frequency of administration, use of vaccination in men, public acceptance and behavior, appropriate populations to be vaccinated, etc. Most unresolved questions will be answered over time. The new vaccines embody a big promise to humanity, although we still have to overcome the financial burden and possible late side effects of the vaccine.
Safra
Tamar
T
D005260:Female; D006801:Humans; D015994:Incidence; D065006:Papanicolaou Test; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D014626:Vaginal Smears
D053918:Papillomavirus Vaccines